Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts Details-
Title Grant Type Focus Area Country Application Due Date Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology Brazil, Chile, India, Italy, South Africa, Spain, United Kingdom Guideline Concordant Care and New Data for Patients with MIBC through la/mUCEducation Oncology USA Clinical Research Studies of Atirmociclib in HR+/HER2- and/or HER2+ Breast CancerRelease Date:Research Oncology Australia, Brazil, Canada, China, France, Germany, Italy, Japan, Korea, Mexico, Spain, Taiwan, USA, United Kingdom Quality Improvement Interventions to Enhance the Care of Patients Infected by MBL-CRE or S. maltophiliaRelease Date:Quality Improvement Inflammation & Immunology Australia, Chile, India, Italy, Spain, United Kingdom Advancing Real-World Evidence in Idiopathic Inflammatory Myopathies Through a German Disease RegistryRelease Date:Research Inflammation & Immunology Germany Real-World Evidence on Clinical Outcomes with ATM-AVI in Adult Patients with Stenotrophomonas maltophilia InfectionsRelease Date:Research Inflammation & Immunology China Real-World Evidence on Clinical Outcomes with Aztreonam-Avibactam (ATM-AVI) in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China Tissue Penetration and Correlation with Clinical Outcomes of ATM-AVI in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China Advancing Multidisciplinary Care in HemophiliaRelease Date:Quality Improvement Rare Disease China BCMA BsAb Educational Initiatives in 2L+ Relapsed/Refractory Multiple MyelomaRelease Date:Education Oncology USA -
Title Grant Type Focus Area Country Application Due Date An Accord for a Healthier World: Digital Health Tools to Improve Multidisciplinary Patient CareRelease Date:Quality Improvement Support for the Professions Senegal PARP-inhibitor Combination Treatments in Prostate CancerRelease Date:Education Oncology China Improving cancer care in patients with metastatic breast cancerRelease Date:Quality Improvement Oncology Kazakhstan An Accord for a Healthier World: Preceptorships for Rheumatology (African French Speaking Countries Geographic Scope)Release Date:Education Inflammation & Immunology All Improving Health Equity in IBD through Disparities ResearchRelease Date:Research Inflammation & Immunology All Emerging Science in the Management of Acute Myeloid LeukemiaRelease Date:Education Oncology All Addressing Systemic Drivers of Racial Health InequitiesRelease Date:Quality Improvement Health Equity USA Diversity in Postmarketing Drug Safety SurveillanceRelease Date:Research Patient Safety USA Addressing Barriers to Care: Destigmatizing Breast Cancer through Patient EducationRelease Date:Education Oncology Ghana, Rwanda Increasing Awareness and Understanding of Duchenne Muscular Dystrophy in Latin America, Africa, Middle East and Asia-PacificRelease Date:Education Rare Disease All Improving Education Disparities of Young Gatroenterologists to Deliver Appropriate Medical Care to IBD PatientsRelease Date:Education Inflammation & Immunology Argentina, Brazil, India, Malaysia, Mexico, Russia, Saudi Arabia, Singapore, Turkey, United Arab Emirates 2023 Inflammatory Bowel Disease (IBD) Fellowship – IndiaRelease Date:Fellowship Inflammation & Immunology India